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REVIEW
Limiting the morbidity of inguinofemoral lymphadenectomy in vulvar cancer
patients; a review
Anne-Floor W. Pouwera, Henriette J. Artsb, Jacobus van der Veldenc and Joanne A. de Hullua
aDepartment of Obstetrics and Gynaecology, Radboud university medical center, Nijmegen, The Netherlands; bDepartment of Obstetrics and
Gynaecology, University Medical Center Groningen, Groningen, The Netherlands; cDepartment of Obstetrics and Gynaecology, Center for
Gynaecologic Oncology Amsterdam (location: Academic Medical Center), Amsterdam, The Netherlands
ABSTRACT
Introduction: Inguinofemoral lymphadenectomy (IFL) is performed in the treatment for vulvar cancer.
One or more complications after IFL is reported in up to 85% of the patients. This review presents an
overview of surgical techniques and peri- and post-operative care that has been studied in order to
reduce the morbidity associated with IFL in vulvar cancer patients.
Areas covered: Current knowledge on post-operative complications after different surgical techniques
and peri- and post-operative protocols were discussed. A systematic literature review was conducted
using MEDLINE, EMBASE and the Cochrane library on 20 February 2017. In order to be eligible for
inclusion, studies must report the associated post-operative morbidity per surgical technique, or peri- or
post-operative care given after IFL in vulvar cancer patients.
Expert commentary: After the implementation of several new surgical techniques, the morbidity after
IFL decreased but remains high and clinically meaningful. More research is needed on surgical
techniques and peri-or post-operative care to further reduce the complication rates after IFL in vulvar
cancer patients.
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Vulvar cancer is the fourth most common gynecologic cancer
after endometrial, ovarian, and cervical cancer. Vulvar cancer is
a rare disease with an incidence of 2.4 per 100,000 women [1].
Over the past few decades, the incidence of vulvar cancer
increased [2]. Vulvar cancer mostly affects elderly women,
with more than half of the patients being above the age of
70 years at the time of diagnosis. The most common histolo-
gical type of vulvar cancer is squamous cell carcinoma (SCC),
which accounts for over 80% of the cases [3].
The dissemination of vulvar SCC may occur by three differ-
ent routes: direct extension, lymphogenic spread, and hema-
togenic spread. The initial spread occurs usually to the
inguinofemoral lymph nodes. As soon as the depth of infiltra-
tion is more than 1 mm, inguinofemoral lymph node metas-
tases can already be present. Therefore, evaluation of
inguinofemoral lymph nodes is crucial. The cornerstone in
the treatment of primary vulvar SCC is surgery, consisting of
both local tumor resection and inguinofemoral lymph node
staging and/or dissection. The treatment for vulvar cancer has
developed throughout the last decades. For years, radical
vulvectomy with ‘en bloc’ bilateral inguinofemoral lymphade-
nectomy was a well-established treatment. In the last three
decades, less radical surgery was introduced to decrease mor-
bidity with comparable or improved prognosis. Nowadays, the
standard treatment of early stage vulvar SCC consists of radi-
cal local excision of the tumor combined with a sentinel node
(SN) procedure and/or inguinofemoral lymphadenectomy
(IFL). The SN procedure is safe to perform instead of an IFL
in patients with a unifocal tumor <4 cm without suspicious
lymph nodes in the groins [4]. In patients with a larger tumor,
multifocal disease and/or a positive SN and in patients with
local recurrent disease without earlier IFL, an IFL is indicated.
After the implementation of the SN, in approximately half of
the patients with vulvar SCC an IFL is still indicated [5].
Unfortunately, IFL is associated with significant short- and
long-term complications. The occurrence of one or more groin
wound complications is reported in 66–85% of the patients
[6,7]. Wound breakdown, wound infection, lymphoceles, lym-
phedema, cellulitis, and erysipelas are the most reported com-
plications. Because IFL will always have a place in the
treatment of vulvar cancer, it is important to look for adjust-
ments, which may reduce the associated morbidity.
The aim of this review is to create an up-to-date summary
of surgical techniques and peri- and postoperative care that




We performed a systematic search of the literature on 20
February 2016 using MEDLINE, EMBASE, and the Cochrane
library. The following search (MeSH)terms and synonyms
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were used for ‘lymphadenectomy’ combined with ‘vulvar can-
cer’ (lymphadenectomy, inguinofemoral lymphadenectomy,
groin surgery, groin dissection, lymph node dissection,
lymph node surgery, lymph node excision; vulvar cancer, vul-
var tumor, vulvar carcinoma, vulvar neoplasm, vulvar squa-
mous cell carcinoma). The search was restricted to the
English and Dutch language.
2.2. Study selection
In order for an article to be eligible, the following predefined
criteria had to be met [1]: (randomized) (un)controlled trial; con-
trolled or uncontrolled prospective or retrospective study [2]; IFL
for vulvar cancer patients aged >18 years; and [3] report the
associated complication rate per studied surgical technique or
peri- or postoperative care.
2.3. Outcome measures
Our primary outcomes of interest were
● Complication rate per surgical technique and/or peri-, or
postoperative care




● Long-term complications >8 weeks surgery
● Cellulitis or erysipelas (recurrent)
● Lower extremity lymphedema
Secondary outcome of interest was
● Quality of life
2.4. Data extraction and analysis
Relevant data on study population, study design, surgical
technique, peri-or postoperative protocol, and the complica-
tion rates were extracted from the included studies. Similar
complications were grouped together such as seroma and
lymphocele, cellulitis and erysipelas, wound dehiscence and
wound breakdown.
Quality of the included studies was categorized according
to the levels for intervention studies of evidence of the Oxford
Centre of Evidence Based Medicine [8]. Level one evidence
included a systematic review of randomized controlled trials
(RCT), level two evidence included a randomized trial, level
three, a non-RCT, level four, case-series, case-control studies,
or historically controlled studies.
The aim of this review was to create an up-to-date sum-
mary of all available evidence regarding surgical techniques
and peri- and postoperative care protocols after IFL in vulvar
cancer patients. Therefore, we included all published articles
concerning this subject. As both controlled and uncontrolled




The search yielded a total of 1988 articles, and after removal of
duplicates, 1363. One author (AP) screened all titles and
checked for relevant abstracts; 123 abstracts were found to
be relevant and were retrieved in full text. The same author
assessed the articles for eligibility using the predefined criteria
as stated in our methods. A total of 36 studies were included
in this review.
3.2. Study characteristics
The research designs of the included studies were mainly
retrospective (23 studies), six were prospective uncon-
trolled studies, five RCTs, and two prospective controlled
studies. Study populations ranged between 5 and 194
patients and were studied in the period from 1955 until
2016. The quality of the included studies was mainly level
four evidence (31 studies). Two included RCTs were down-
graded to level three evidence because they did not per-
form a sample size calculation and both included less than
15 patients [9,10] (See Table 1).
The following surgical interventions were studied: separate
incisions or radical vulvectomy with ‘en bloc’ lymphadenect-
omy, unilateral IFL, sparing of saphenous vein, Sartorius trans-
position, dura mater for femoral vessel coverage, minimally
invasive technique, preservation of fascia lata, harmonic scal-
pel or electrosurgery, plasmajet, VH fibrin sealant, lymphatic
microsurgical venous anastomosis (LYMPHA technique), lym-
phatic flap, method of skin closure, anticoagulation, post-
operative drainage and compression garments. None of the
included studies reported data on quality of life. For an over-
view of the association of the above-described interventions
on postoperative morbidity after IFL, see Table 2.
3.3. Modifications of surgery
3.3.1. Type of groin incision
The morbidity of IFL by type of groin incision was reported by
ten included studies; both separate incisions and the ‘en bloc’
approach were described. See Table 3.
Only two retrospective studies studied postoperative
complications after IFL by separate incisions versus the
‘en bloc’ approach [14,15]. Helm et al. [14] did report a
reduction of patients with wound breakdown using sepa-
rate incisions but this reduction was not statistically sig-
nificant. The second study described a reduction of the
wound breakdown rate and an increase in lymphoceles
after using separate incisions, but did not perform any
statistical tests [15]. Six other studies report the incidence
of postoperative complications after the use of separate
incisions without a control group. Overall, it can be con-
cluded that the occurrence of wound breakdown, lymphe-
dema, and cellulitis/erysipelas was reduced by using
separate incisions with an increase in lymphoceles.
To determine further reduction of the morbidity associated
by IFL using separate incisions, Manci et al. [30] compared skin
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access above or below the inguinal ligament in a RCT and
found an advantage for incision above the ligament; wound
dehiscence in 32% versus 17%, lymphocele in 19% versus 6%,
respectively, although there was no statistically significant
difference.
3.3.2. Laterality of IFL
Unilateral IFL as an alternative to bilateral IFL was studied
in a selected group of patients with lateralized tumors
(tumor with medial margin >1 cm from the midline) with-
out palpable groin lymph nodes. Two studies reported less
complications in unilaterally treated patients [17,22]. The
number of patients with wound dehiscence or lymphe-
dema is significantly reduced by performing a unilateral
IFL from 24% to 0% and 67% to 8%, respectively
(p < 0.001) [22]. In conclusion, unilateral IFL does reduce
morbidity but can only safely be performed in patients
with early stage and lateralized vulvar cancer [17].
3.3.3. Sparing of the saphenous vein
The classic description of IFL includes ligation of the saphe-
nous vein. It was suggested that sparing the saphenous vein
might reduce the complications associated with IFL. Four
retrospective studies reported the complication rates after
sparing versus ligation of the saphenous vein [20,23,26,27].
See Table 4 for an overview of the outcomes of these studies.
There was a significant lower number of groins with wound
infection [23,26], wound breakdown [20,23,26], lymphedema
[23,26,27], and cellulitis/erysipelas [20,27] after sparing of the
saphenous vein. There was no evidence of effect for the
reduction of lymphoceles. It can be concluded that sparing
of the saphenous vein reduces the postoperative wound com-
plications after IFL.
3.3.4. Coverage of femoral vessels
The transposition of the Sartorius was first introduced by Way
as modification to protect the femoral vessels in case of
Table 1. Characteristics of included studies.
Study Year Design Patients Intervention Control Level of evidence
Hacker 1981 [11] 1957–1978 Retrospective 100 Separate incisions * 4
Piver 1983 [12] 1957–1971 Retrospective 115 Sodium warafin, dextran, none Heparine 4
Podratz 1983 [7] 1955–1975 Retrospective 175 ‘en bloc’ approach 4
Fiorica 1991 [13] 1987–1990 Prospective 20 Cadaver dura mater * 4
Helm 1992 [14] 1969–1988 Retrospective 64 Separate incisions ‘en bloc’ approach 4
Lin 1992 [15] 1970–1988 Retrospective 82 Separate incisions ‘en bloc’ approach 4
Finan 1994 [16] 1991–1992 Prospective 11 Artificial dura film * 4
Burke 1995 [17] 1978–1994 Retrospective 76 Bilateral and/or unilateral IFL * 4
Paley 1997[18] 1975–1994 Retrospective 101 Sartorius transposition Not Sartorius transposition 4
Bell 2000 [19] 1990–1998 Retrospective 60 Preservation of the fascia lata * 4
Zhang 2000 [20] 1990–1998 Retrospective 83 Preservation saphenous vein Ligation saphenous vein 4
Gould 2001 [21] 1992–1999 Retrospective 67 Separate incisions * 4
Gori 2002 [22] 1992–1997 Retrospective 45 Unilateral IFL Bilateral IFL 4
Gaarenstroom 2003 [6] 1993–2000 Retrospective 101 Separate incisions * 4
Rouzier 2003 [23] 1978–2000 Retrospective 194 Sartorius transposition Not Sartorius transposition 4
Preservation of saphenous vein Ligation saphenous vein
Judson 2004 [24] 1996–2002 RCT 61 Sartorius transposition Not Sartorius transposition 2
Micheletti 2005 [25] 1981–2002 Retrospective 156 Preservation fascia lata * 4
Dardarian 2006 [26] 1992–2003 Retrospective 29 Sparing saphenous vein Ligation saphenous vein 4
Zhang 2007 [27] 1989–2005 Retrospective 64 Preservation saphenous vein Ligation saphenous vein 4
Carlson 2008 [28] 2002–2005 RCT 137 VH fibrin sealant No VH sealant 2
Pellegrino 2008 [29] 2005–2007 Retrospective 42 Harmonic scalpel Conventional electrosurgery 4
Van der Zee 2008 [4] 2000–2006 Prospective 457 Separate incisions * 4
Manci 2009 [30] 2000–2007 RCT 62 Inferior skin incision Superior skin incision 2
Sawan 2009 [10] 2006 RCT 14 Prophylactic compression garments Not prophylactic compression
garments
3
Hinten 2011 [5] 1988–2009 Retrospective 164 ‘en bloc’ approach and separate
incisions
* 4
Madhuri 2011 † [9] Not
reported
RCT 18 Plasmajet Not plasmajet 3





Xu 2011 [32] 2008–2010 Retrospective 17 VEIL abdominal approach * 4
Li 2012 [33] 2004–2009 Retrospective 24 Modified triple incisions * 4
Soliman 2012 [34] 2002–2009 Retrospective 34 Separate incisions * 4
Morotti 2013 [35] 2009–2011 Prospective 15 LYMPHA No LYMPHA (historical cohort) 4
Li 2015 [36] 2007–2013 Prospective 58 Sartorius tendon transposition Sartorius transposition 4
Wang 2015 [37] 2010–2013 Prospective 21 VEIL hypogastric subcutaneous
approach
* 4
Gentileschi 2016 [38] Not
reported
Prospective 5 Lymphatic flap No lymphatic flap 4
Wu 2016 [39] 2011–2016 Prospective 37 VEIL lateral approach * 4
Jain 2017 [40] 2011–2015 Retrospective 12 R-VEIL * 4
†: conference abstract, *: not studied, IFL: inguinofemoral lymphadenectomy, VEIL: video endoscopic lymphadenectomy, LYMPHA: lymphatic microsurgical
preventive healing approach, R-VEIL: robot-assisted video endoscopic inguinal lymphadenectomy.





























































































































































































































































































































































































































































































































































































































































































































































































































































































































618 A. W. POUWER ET AL.
wound breakdown and to decrease the morbidity after IFL
[41]. The effect of transposition of the Sartorius on the com-
plication rate is reported in three studies, one RCT [24] and
two retrospective studies [18,23]. Judson et al. [24] rando-
mized for either sartorius transposition or not. They found a
statistically significant increase of lymphocele formation in
patients in the transposition group. Other outcomes, such as
wound breakdown, wound infection, and lymphedema did
not differ between those two groups of patients.
One retrospective study reported an increase in patients
with lymphedema after transposition of the Sartorius, with
statistical significance [23] and another study reported a reduc-
tion of wound infections after transposition [18]. These studies
did not report significant differences between wound break-
down and lymphocele. See Table 5 for an overview of results.
Another explored surgical technique during IFL to cover
the groin vessels is Sartorius tendon transposition versus
Sartorius transposition as investigated by one case-control
study [36]. Wound breakdown and chronic lymphedema
were significantly reduced in the Sartorius tendon transposi-
tion group, 30% versus 3.6% (p = 0.012) and 33.3 versus 7.1%
respectively (p = 0.022). However, none of the studies report
the morbidity after tendon transposition versus no tendon or
Sartorius transposition.
In the past, cadaver dura mater was used to cover the groin
vessels but this is difficult and more time consuming than
Sartorius transposition, besides the risk of transmittance of
viral infections [13]. The artificial dura mater was not effective
and increased the complications after IFL [16].
In conclusion, there is no evidence that covering the
femoral vessels by transposition of the Sartorius or cadaver
or artificial dura mater does reduce the complications after IFL
in vulvar cancer patients.
3.3.5. Minimally invasive IFL
In the previous years, minimally invasive techniques were
developed for IFL to reduce the postoperative complications.
After the introduction in other malignancies such as penile
cancer and melanoma, video endoscopic IFL (VEIL) was stu-
died in vulvar cancer patients. Until now, there is limited
English literature on vulvar cancer. Four studies concerning
VEIL in vulvar cancer patients were included in this review
[32,37,39,40]. These studies were published between 2011
and 2017, two were prospective and two retrospective. In
total, 87 patients were included (75 patients from China and
12 patients from India). For results see Table 6.
Xu et al. used the abdominal approach for VEIL and
reported no inguinal wound-related complications besides
one patient with exhibited lymphorrhea through the drain
orifice [32]. The second study used a hypogastric subcuta-
neous approach and reported only one patient with a lym-
phocele (5%); furthermore, no other inguinal wound
complications were observed [37]. The third study used a 3-
incision lateral approach to perform VEIL in 37 patients and
was the largest published study in vulvar cancer patients. They
described wound breakdown in 3% of the patients; no other
complications such as wound infection, lymphocele, lymphe-
dema, and cellulitis were reported in these patients [39]. The






































































































































































































































































































EXPERT REVIEW OF ANTICANCER THERAPY 619
to perform IFL. Reported overall complication rate was 75%
per patient and 60% per groin [40]. These overall complication
rates reported after R-VEIL were even higher to those reported
after open IFL by Gaarenstroom et al. of 66% per patient and
52% per groin, respectively [6]. Furthermore, it is unclear if (R-)
VEIL is safe in vulvar cancer patients, given a groin recurrence
rate as high as 6% in patients using VEIL [39] comparing to
2.5% after using the conventional procedure [42].
In conclusion, (R-)VEIL seems to be feasible for the
approach of IFL as described in all studies, but it remains
questionable if (R-)VEIL reduces the postoperative complica-
tions, and whether this procedure is oncologically safe or not.
3.3.6. Other modifications
More individual studies report modifications on the current
surgical techniques of IFL. First of all, the preservation of the
fascia lata. Two retrospective studies report after sparing of
the fascia lata lower rates of lymphocele, lymphedema, wound
infection, and wound breakdown compared to the literature
[19,25] and overall short-term complication rate of 38% and
long-term complication rate of 14% [25].
The device used during IFL is studied as a possible option to
reduce the morbidity. Pellegrino et al. [29] investigated the
differences in postoperative complications of using either the
harmonic scalpel or conventional electrosurgery. They did not
report significant differences between these two groups in the
incidence of postoperative complication. In this study, only one
patient had a postoperative complication in the harmonic scal-
pel group (including 22 patients) versus zero patients in the
conventional electrosurgery group (including 20 patients).
Another study regarding the surgical device used is performed
by Madhuri et al. [9] using Plasmajet (a surgery system utilizing
kinetic energy and highly controlled thermal effects to seal the
tissue). In a conference abstract, they described a pilot RCT in 18
patients and concluded that Plasmajet may reduce the lympho-
cele formation but did not publish the full paper until now.
Another studied option is the sealing of lymph vessels
during IFL, evaluated by Carlson et al. [28] in a RCT. They
investigated the addition of VH fibrin sealant sprayed in the
groin before sutured closure. Inguinal infections, wound
breakdown, lymphoceles, and lymphedema did not signifi-
cantly differ between the two groups. However, they reported
a significant increase in the number of vulvar infections in
patients treated by VH fibrin sealant (33% versus 14%,
p = 0.0098).The overall complication rate for patients treated
in the intervention group was 61% versus 59% in the control
group. In conclusion, VH fibrin sealant in the groin did not
reduce the groin complications after IFL and increased the
vulvar wound complications.
The use of lymphatic microsurgical preventive healing
approach (LYMPHA) in the prevention of lymphedema during
IFL was described by one prospective study in 23 groins [35].
Before incision of the skin, blue dye was injected in the thigh
muscles to identify the lymphatic vessels; anatomizes were
made between lymphatics from the lower limb and one of
the collateral branches of the femoral vein. They reported
lymphedema in 8% of the groins after the LYMPHA technique
and 36% in the cohort without LYMPHA technique after a



















































































































































































































































































































































620 A. W. POUWER ET AL.
complications were not reported. More research is needed
before implementation of this technique. Another study used
a surgical technique for microsurgical reconstruction of the
lymphatic drainage in order to prevent lymphatic drainage
impairment. In this study, a lymphatic flap harvested from
the flank was used to create a bridge in the gap of lymphatic
vessels created by IFL. This technique was used in one groin,
while the conventional surgical method was used for the other
groin. Patients were evaluated 6 months after surgery, and the
limbs treated by the lymphatic flap showed mild edema ver-
sus moderate to severe edema in the untreated limb [38].
The method of skin closure was studied by one retrospec-
tive study [31]: continuous subcuticular suture was compared
to staples. Lymphocele formation was reduced (21% versus
47%, p = 0.05) and also a reduction in chronic lymphedema
(6% versus 29%, p = 0.02) by using subcuticular suture com-
pared to staples. Wound infection and wound breakdown
were not influenced by the method of skin closure.
3.4. Modifications of perioperative care
In 1983, one study reported the influence of perioperative
prophylactic anticoagulation as a possible cause of lympho-
cele after IFL. In patients receiving heparin, 42% developed a
lymphocele versus 2% in patients receiving sodium warfarin,
dextran, or no anticoagulation (p < 0.01). The influence of both
treatment regimens on the risk of embolism in these patients
is unclear. There are no other studies regarding prophylactic
anticoagulation and the associated risk of complications after
IFL besides this dated publication. Nowadays, the use of
heparin is more and more replaced by the use of low-mole-
cular-weight heparin during surgery and postoperative care.
No reports about usage of low-molecular-weight heparin are
published until now.
The usage of prophylactic intravenous antibiotics is widely
accepted during perioperative care, but there were no pub-
lications about reducing postoperative (wound) complications.
3.5. Modifications of postoperative care
The postoperative care given might influence the morbidity
after IFL. First of all, the postoperative drainage of the groin
after IFL might reduce the morbidity. The optimal duration of
lymph fluid drainage was studied by only two retrospective
studies. Walker et al. [31] reported complications in association
with the duration of lymph fluid drainage. The main reason for
removal of the drain was production of <50 ml per 24 hours.
Wound breakdown and lymphedema were significantly lower in
the group of patients drained over 7 days compared to shorter
drainage. There was no influence on the number of patients
with a wound infection and lymphocele. Another retrospective
study showed that higher drain production on the last day in
situ was associated with an increased risk for any short-term
complication but there was no effect found on duration drain in
situ on the complication rate [5]. Prospective research is needed
to determine the optimal duration of postoperative drainage in
terms of reduction of complications after IFL.
The second studied modification of postoperative care was
the use of prophylactic compression garments by Sawan et al.
[10] in 14 patients. Patients were randomly assigned for pro-
phylactic compression garments or best supportive care with-
out compression garments. There was no statistically
significant difference in postoperative complication rate
regarding wound breakdown, wound infection, lymphocele,
and lymphedema. Further (larger) studies are needed to inves-
tigate the role of compression garments for reducing the
morbidity of IFL.
4. Expert commentary
Where feasible we advise the implementation of separate
incisions, unilateral IFL, sparing of the saphenous vein, pre-
servation of the fascia lata, and continuous suture as the
standard care for IFL in vulvar cancer patients. These surgical
techniques appear to reduce the complication rates. The
usage of perioperative fibrin sealant, the ‘en bloc’ approach,
bilateral IFL (for lateralized tumors), and artificial dura mater
should not be used as a standard surgical technique for IFL
given the higher complication rates. Sartorius transposition,
skin access above or below the inguinal ligament, and cadaver
dura mater did not influence the complication rate and should
not be implemented for IFL. Minimally invasive approach for
IFL is promising in terms of reduced of complication rates, but
the oncological safety remains unclear. Therefore, minimally
invasive techniques for IFL should only be used within the
protection of a prospective trial.
Regarding the postoperative care, there is no consensus
about optimal drain management and it remains unclear if
prophylactic compression garments do reduce the postopera-
tive complication rates. Peri- and postoperative protocols
should be studied more extensively before the implementa-
tion of new protocols.
Concerning the surgical technique in vulvar cancer
patients, the implementation of separate incisions decreased
Table 6. Minimally invasive approach for IFL, complications in percentages.
Short term Long term
Study N Wound infection Wound breakdown Lymphocele Lymphedema Cellulitis/erysipelas Overall ≥1 complication
Per patient
Xu 2011 17 0 0 0 0 0 0
Wang 2015 21 – – 5 – – –
Wu 2016 37 – 3 0 – 0 –
Jain 2017 12 0 0 33 33 17 75‡
Per groin
Jain 2017 22 0 0 27 27 9 60‡
‡: including prolonged lymphhorrhea; –: not reported.
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the morbidity after IFL. A RCT comparing the ‘en bloc’
approach versus separate incisions investigating the oncologic
safety is lacking. However, in a Cochrane review, all observa-
tional studies concerning separate incisions were pooled and
they concluded that separate incisions were deemed to be
oncologically safe [43].
Another surgical technique which appears promising in
terms of reduction of postoperative morbidity is minimally
invasive IFL. Recently, two reviews were published on this
subject [44,45]. One review included ten studies including
236 procedures in 168 patients with penile, vulvar, or vagi-
nal cancer or melanoma. They concluded that the number of
wound infections, wound dehiscences, and lymphoceles
appeared lower in patients operated by the VEIL technique
(overall complication rate 4% of the groins) compared to the
open technique [44]. The other systematic review reported
an overall complication rate of 13% (lymphocele formation
3.6%, wound infection 1.2%, and lymphedema 0.4%) [45].
This review included nine studies, but only three out of
these were published in English. One was included in our
review [32], the others were excluded for this review (one
study included also vaginal cancer patients and the other
did not report data about postoperative complications). So
far, no RCTs assessed this new minimally invasive surgical
technique. Furthermore, none of the studies included
Caucasian women. Moreover, the usage of an ultracision
scalpel, which has proven to reduce the incidence of lym-
phoceles after axillary dissection in breast cancer patients
[46], which is used during VEIL and not during the open
procedure may partly explain the differences in complication
rates. The results on decreasing the incidence of postopera-
tive complications by using the minimally invasive approach
are promising, but the oncologic safety of this technique is
still unclear. The main concern is the high groin recurrence
rate of 6.5% in patients with negative lymph nodes after
VEIL [39]. The oncologic safety of pelvic lymph node dissec-
tion by laparoscopy is proven for other gynecological malig-
nancies, no differences in number of lymph nodes removed,
disease recurrence and survival were reported in several
studies [47,48]. A large prospective trial with adequate fol-
low-up of at least 2 years is needed to determine the
oncologic safety of VEIL and the postoperative outcomes in
Caucasian women with vulvar cancer.
IFL is also performed in patients with a melanoma or penis
cancer. In order to reduce bias, in our review only studies
including patients with vulva cancer were included. There
were several reasons for excluding other indications for IFL
than vulvar cancer. First of all, the median age of patients with
melanoma is lower than in patients with vulvar cancer; older
patients are faced with more comorbidity than younger
patients which plays a role in the incidence of postoperative
complications. Furthermore, the sex of a patient may influence
the complication rate after IFL; therefore, studies on penis
cancer, including only men, were excluded from this review.
However, more studies on the complications after IFL for
melanoma and after axillary dissection for breast cancer are
published. Regarding the complications after IFL in melanoma
patients, a review included seven studies described different
surgical approaches for IFL; applying fibrin sealant in the
wound bed, different incision techniques for separate inci-
sions, local versus general anesthesia, early mobilization or
postoperative bed rest were studied, but none of these inter-
ventions showed a statistically significant reduction in compli-
cation rates [49]. A review concerning seroma formation after
axillary dissection in breast cancer patients reported a
decrease in complications by using ultrasonic scissors, electro-
termal bipolar vessel system, suture fixation techniques to
reduce the dead space, volume-controlled suction drainage,
and active shoulder exercise [50].
There are some limitations to this review. First of all, there
is a lack of published studies with level one evidence. As
vulvar cancer is a rare disease, it is hard and not realistic to
perform a large number of RCTs in vulvar cancer patients.
Therefore, this review was mainly based on data from retro-
spective or observational studies, which is a source of bias.
Another limitation was the different definitions used for com-
plications after IFL. An attempt should be made to standardize
the definitions used for postoperative wound complications in
vulvar cancer patients for this will improve the comparability
between published studies in the future.
5. Five year view
Even though new surgical modifications were implemented,
the complication rate after IFL in vulvar cancer patients
remains high. In the near future, more research is expected
to further reduce this morbidity. Besides research on reducing
the complications after IFL, research will focus on new treat-
ment regimens in order to limit the indication for IFL.
Reducing the number of patients with an indication for IFL
can be achieved by the introduction of a repeat SN procedure
and/or radiotherapy on the groin. However, it should be kept
in mind that the consequences of a groin recurrence are
significant, with a 5-year survival rate of only 0–15% [51–53].
Therefore, determination of the lymph node status remains an
important part in the treatment of vulvar cancer patients.
The safety of a SN procedure in patients with a local
recurrence of vulvar SCC has not been proven yet [54]. As a
consequence, patients with a local recurrence after an earlier
negative SN do not perceive the benefits of the SN procedure
in terms of the omission of an IFL. Research concerning the
safety of a (repeat) SN procedure instead of an IFL in patients
with recurrent vulvar SCC is expected within the upcoming
years.
In 2018, results will be expected of the GROINSS-VII study
that will provide more information on the safety and efficacy
of radiotherapy instead of IFL in patients with micro-metas-
tases in the sentinel lymph nodes.
Replacement of IFL by other treatment options with less
treatment-related morbidity but the same effectiveness and
safety will be a step forward in treating vulvar SCC patients.
For patients who still have an indication for IFL, research is
expected on minimally invasive techniques for IFL to deter-
mine the oncologic safety and the benefits in terms of
reduced postoperative morbidity. Furthermore, the device
used during surgery may be a key factor in preventing post-
operative complications. Peri- and postoperative care may also
play an important role and also affect the postoperative
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complication rates. More prospective studies regarding the
peri-and postoperative care should be performed.
Key issues
● Inguinofemoral lymphadenectomy (IFL) is a part of the
treatment for approximately half of the patients with pri-
mary or recurrent vulvar squamous cell carcinoma.
● IFL in vulvar cancer patients is associated with post-opera-
tive groin wound complications such as wound infection,
wound breakdown, lymphocele, lymphedema and cellulitis
or erysipelas in up to 85% of the patients.
● This review is an up to date summary of surgical techniques
and peri- and postoperative care protocols that have been
studied to reduce this morbidity
● Surgical techniques such as separate incisions for IFL, uni-
lateral IFL, sparing of the saphenous vein, preservation of
the fascia lata and continuous skin suture do reduce the
postoperative complications.
● Peri- and postoperative care is described in a few publica-
tions; it remains unclear if peri-operative prophylactic antic-
oagulation or antibiotics influences the number of
postoperative complications. The use of post-operative pro-
phylactic compression garments does not reduce post-
operative complications. There is no consensus on the
optimal duration of drainage of the groin in order to pre-
vent postoperative complications.
● After the implementation of several new surgical techni-
ques, the morbidity after IFL decreased but remains high
and clinically meaningful.
● More research is needed on surgical techniques and peri-or
postoperative care to further reduce the complication rates
after IFL in vulvar cancer patients.
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